Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Potus

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Circulation|June 26, 2014
Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3pSalil Sharma, Soban Umar, Francois Potus, et al.
Circulation Research|March 29, 2020
Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular FibrosisLian Tian, Danchen Wu, Asish Dasgupta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial HypertensionAlice Bourgeois, Sébastien Bonnet, Sandra Breuils-Bonnet, et al.
Thorax|July 6, 2021
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertensionWen-Hui Wu, Sébastien Bonnet, Tsukasa Shimauchi, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2022
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial HypertensionRuaa Al-Qazazi, Patricia D A Lima, Sasha Z Prisco, et al.
Circulation|July 24, 2020
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial HypertensionJunichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2016
Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial HypertensionGrégoire Ruffenach, Sophie Chabot, Virginie F Tanguay, et al.
The Journal of Clinical Investigation|January 26, 2021
17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelinAndrea L Frump, Marjorie Albrecht, Bakhtiyor Yakubov, et al.
Nature Cardiovascular Research|August 28, 2024
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertensionFatemeh Khassafi, Prakash Chelladurai, Chanil Valasarajan, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Circulation|June 26, 2014
Apolipoprotein A-I mimetic peptide 4F rescues pulmonary hypertension by inducing microRNA-193-3pSalil Sharma, Soban Umar, Francois Potus, et al.
Circulation Research|March 29, 2020
Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular FibrosisLian Tian, Danchen Wu, Asish Dasgupta, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 17, 2019
Inhibition of CHK 1 (Checkpoint Kinase 1) Elicits Therapeutic Effects in Pulmonary Arterial HypertensionAlice Bourgeois, Sébastien Bonnet, Sandra Breuils-Bonnet, et al.
Thorax|July 6, 2021
Potential for inhibition of checkpoint kinases 1/2 in pulmonary fibrosis and secondary pulmonary hypertensionWen-Hui Wu, Sébastien Bonnet, Tsukasa Shimauchi, et al.
American Journal of Respiratory and Critical Care Medicine|June 14, 2022
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial HypertensionRuaa Al-Qazazi, Patricia D A Lima, Sasha Z Prisco, et al.
Circulation|July 24, 2020
Identification of Long Noncoding RNA H19 as a New Biomarker and Therapeutic Target in Right Ventricular Failure in Pulmonary Arterial HypertensionJunichi Omura, Karima Habbout, Tsukasa Shimauchi, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2016
Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial HypertensionGrégoire Ruffenach, Sophie Chabot, Virginie F Tanguay, et al.
The Journal of Clinical Investigation|January 26, 2021
17β-Estradiol and estrogen receptor α protect right ventricular function in pulmonary hypertension via BMPR2 and apelinAndrea L Frump, Marjorie Albrecht, Bakhtiyor Yakubov, et al.
Nature Cardiovascular Research|August 28, 2024
Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertensionFatemeh Khassafi, Prakash Chelladurai, Chanil Valasarajan, et al.
Pageof 2